BioHealth News Archive
Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia Gravis – Cartesian
GAITHERSBURG, Md., May 10, 2022 – Cartesian Therapeutics, a fully integrated clinical-stage biotechnology company pioneering RNA cell therapy in and beyond oncology, will present late-breaking…
Read More
Virginia’s Pocket Life Science Ecosystems are Booming · BioBuzz
There is no doubt that Virginia is open for business to the life sciences industry. Over the past several years, the state has seen…
Read More
Trammell Crow Company Announces Plans for a Life Sciences Campus in Maryland
The Labs at Belward, located at the Belward Campus of The Johns Hopkins University, will Initially Provide 757,000 SF of Trophy Lab and R&D…
Read More
How can your BioHealth business benefit from a review by BHI industry experts? Please register for our next Entrepreneur-In-Residence (EIR) day on May 18th and find out. To sign-up for any of the EIR dates in 2022, please follow this link.
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re…
Read More
The venture slowdown isn’t coming — it’s here | TechCrunch
The pace at which venture capitalists are deploying funding across the globe slowed yet again in April. Venture capital dollar volume, as tracked by…
Read More
University of Maryland Launches New Center to Bring Health Care’s Vision of Tomorrow Into Focus
COLLEGE PARK, Md. (PRWEB) May 05, 2022 Ultrasound data displayed directly on a patient via augmented reality headsets. Immersive "grand rounds" for medical students…
Read More
Scheer Partners to Deliver More Spec-suites and Build-to-Suit Space in Maryland  · BioBuzz
It’s been a big few years in the Biohealth Capital Region, especially big for commercial real estate firm Scheer Partners. After the success of…
Read More
Special Edition BioTalk: Dave Saunders, CTO & Co-Founder of Galen Robotics
Dave Saunders, CTO & Co-Founder of Galen Robotics, joins Rich Bendis before their 5/6/2022 Open House in Baltimore. (RSVP to OPENHOUSE@GALENROBOTICS.COM to attend) Also,…
Read More
Virginia Based AMPEL BioSolutions’ Machine Learning Breakthrough Predicts Drug Options for Inflammatory Skin Diseases
CHARLOTTESVILLE, Va., May 3, 2022 — AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat inflammatory skin diseases, such as Lupus,…
Read More
Washington D.C. Mayor Bowser Announces $92 Million Initiative to Catalyze Health Innovation and Address Disparities
Thursday, April 28, 2022 The HOPE Initiative will utilize federal funds to create new lab space, technology advancement & new services (Washington, DC) Today, Mayor…
Read More
Vita Therapeutics relocates to University of Maryland Biopark
From its new headquarters and lab space, the biotech company aims to generate state-of-the-art cellular therapeutics for the treatment of debilitating neuromuscular diseases and…
Read More
How can your BioHealth business benefit from a review by BHI industry experts? Please register for our next Entrepreneur-In-Residence (EIR) day on May 18th and find out. To sign-up for any of the EIR dates in 2022, please follow this link. (2)
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re…
Read More
Rockville’s Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
First novel, nonstimulant option for adults with ADHD in 20 years ADHD affects an estimated 10 million adults in the U.S. ROCKVILLE, Md., April 29, 2022 (GLOBE…
Read More
Maryland Commerce Secretary Mike Gill Guests on BioTalk with Rich Bendis Podcast
Mike Gill, Maryland Commerce Secretary, visits BioTalk to discuss Life Sciences in the State, growing the economy, and how we can continue building on…
Read MoreKite’s Maryland CAR T-cell therapy site gets FDA go-ahead
Kite, a Gilead company, says the US Food and Drug Administration (FDA) has approved commercial production at the company's new CAR T-cell therapy manufacturing…
Read More